Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Methylprednisolone in COVID-19 Pneumonia
NCT04673162Phase 3Completed
- Sponsor
- Azienda USL-IRCCS di Reggio Emilia
- Start
- Dec 2020
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone injection in COVID-19 pneumonia, sponsored by Azienda USL-IRCCS di Reggio Emilia. Started Dec 2020; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04673162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04673162.